[Held on June 30] How to Prevent Unwanted 'Fertility Treatment Resignation'? Considering from the Voices of Those Affected and Advanced Corporate Cases - Kickoff Event of the 'Project for Balancing Work and Fertility Treatment'

Key facts

• [Held on June 30] How to Prevent Unwanted 'Fertility Treatment Resignation'? Considering from the Voices of Those Affected and Advanced Corporate Cases - Kickoff Event of the 'Project for Balancing Work and Fertility Treatment'
• Merck Biopharma Co., Ltd., the Japanese subsidiary of Merck KGaA, has launched a project to balance work and fertility treatment. A kickoff event will be held on June 30, 2026, to discuss support measures involving companies, medical professionals, and affected individuals.
• Source: PR TIMES
• Date: Mon Jun 08 2026 14:00:02 GMT+0900 (Japan Standard Time)

Direct answer

Merck Biopharma Co., Ltd., the Japanese subsidiary of Merck KGaA, has launched a project to balance work and fertility treatment. A kickoff event will be held on June 30, 2026, to discuss support measures involving companies, medical professionals, and affected individuals.

Citation

[Held on June 30] How to Prevent Unwanted 'Fertility Treatment Resignation'? Considering from the Voices of Those Affected and Advanced Corporate Cases - Kickoff Event of the 'Project for Balancing Work and Fertility Treatment' (Mon Jun 08 2026 14:00:02 GMT+0900 (Japan Standard Time)), PR TIMES

Source

PR TIMES

Date

Mon Jun 08 2026 14:00:02 GMT+0900 (Japan Standard Time)